« previous next »
Pages: [1]   Go Down

Author Topic: Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments  (Read 29 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments
« on: October 27, 2024, 03:05:17 PM »
Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear.
Source: Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments
« on: October 27, 2024, 03:05:17 PM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal